Almost Every Dose of Lilly's Zepbound Is in Shortage, FDA Says [BNN Bloomberg (Canada)]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: BNN Bloomberg
Only the lowest dose of Zepbound, which patients usually use only short-term, is listed as “available,” according to a US Food and Drug Administration database. The agency had earlier said just two doses would be in limited supply through the end of April. Dozens of patients have told Bloomberg in recent weeks that they were unable to get the medication at local pharmacies or through online platforms like Amazon Pharmacy or LillyDirect. Part of the problem is producing pre-filled pens that patients use to inject the right dose of the drugs. Making the device requires some of the most complex production systems “on the planet,” Lilly's Chief Executive Officer David Ricks said in August. Read More: Zepbound Pen Shortage Has Patients Clamoring for Vials of Drug Some patients have called for Lilly to release single-dose vials of Zepbound and the diabetes drug Mounjaro to boost supply while the company works to ramp up injector production. The FDA also said shortages of almost all
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly (LLY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Taxpayer to fork out £85bn to cover Bank of England losses [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $885.00 price target on the stock, up previously from $815.00.MarketBeat
- Eli Lilly assures investors it can overcome the high-quality problem of too much demand [CNBC]CNBC
- Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024 [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/16/24 - Form 4
- LLY's page on the SEC website